| «« | April 2025 | »» |
Mon
Tue
Wed
Thu
Fri
Sat
Sun
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 |
Newsletter
Title of Publication :
Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia.
Publication type:
Article in Impact Factor Journal
Journal/Publisher :
BMC Infect Dis. 2020 Jan 10;20(1):30. doi: 10.1186/s12879-019-4741-5.
Keyword(s) :
sofosbuvir
Year :
2020
Project Participant(s) :
Tsertsvadze T, Gamkrelidze A, Nasrullah M, Sharvadze L, Morgan J, Shadaker S, Gvinjilia L, Butsashvili M, Metreveli D, Kerashvili V, Ezugbaia M, Chkhartishvili N, Abutidze A, Kvaratskhelia V, Averhoff F.
Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia.
Akaki Abutidze
If there are some problems please send
Message to administrator
